Cellyan Biotechnology Co Ltd (HKPD) News & Events

$0.347

-0.050 (-14.50%)At close

HKPD News

7.007-17NASDAQ.COM

Cellyan Biotechnology Receives Nasdaq Compliance Extension

8.507-16seekingalpha

Cellyan Biotechnology Secures Nasdaq Compliance Extension

8.501-16seekingalpha

Cellyan Biotechnology (HKPD) Receives Nasdaq Warning for Non-Compliance with $1 Minimum Bid Price

7.001-16Globenewswire

Cellyan Biotechnology Receives Nasdaq Notification for Share Price Below $1

9.012-17Globenewswire

HKPD Approves Major Capital Restructuring at 2025 Annual Meeting

2.012-17Newsfilter

HKPD Restructures Capital Structure Through Shareholder Meeting Approvals

9.008-26Benzinga

Serina Therapeutics Stock Rises Over 25%; Check Out 20 Stocks Making Moves in Premarket Trading

9.005-19Benzinga

Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

9.503-28SeekingAlpha

Hong Kong Pharma Digital Technology gives six months results

9.503-28PRnewswire

Hong Kong Pharma Digital Technology Holdings Limited Reports Financial Results for the Six Months Ended September 30, 2024

Show More News

HKPD Events

6/12 17:00

Cellyan Biotechnology Files $200M Mixed Securities Shelf

Cellyan Biotechnology files $200M mixed securities shelf

3/27 15:30

Cellyan Biotechnology Files to Sell 12.5M Class A Ordinary Shares

Cellyan Biotechnology Co. files to sell 12.5M Class A ordinary shares for holder

1/15 10:42

Hong Kong Pharma opens at $3.50, IPO priced at $4 per share

Hong Kong Pharma Digital Technology Holdings, a provider of OTC pharmaceutical cross-border e-commerce supply chain services in Hong Kong, priced its initial public offering of an aggregate of 1,403,685 ordinary shares at a public offering price of $4.00 per share, of which 1M shares are offered by Hong Kong Pharma and 403,685 shares are offered by the selling shareholders of the company. The shares have begun trading on the Nasdaq Capital Market under the ticker symbol "HKPD". Bancroft Capital is acting as the lead underwriter.

Show More Events

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.